This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook
Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...
$4,950.00 -
23 Aug 2018  |  Europe  |  Market Research
Western European Clinical Laboratory Services Market, Forecast to 2022
Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support
Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...
$4,950.00 -
25 Jun 2018  |  Europe  |  Market Research
Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022
Rise in Cases of Sepsis and Antimicrobial Resistance (AMR) Along with the Focus on Preventative Care will Drive POCT Growth Throughout the Forecast Period
The rise in infectious diseases across Europe has led to a growing need for early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is a vital part of the clinical diagnostics market and is rapidly evolving into the preferred testing mode as rapid infection diagnosis results in lower antibiotic intake, fewer...
$1,500.00 -
06 Nov 2017  |  South Asia, Middle East & North Africa  |  Market Research
Growth and Investment Opportunities in Nepal Healthcare Market, 2017
Incidence of Non-Communicable Diseases increasing leading to demand for specialty services
This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...
$1,500.00 -
23 Jun 2017  |  Europe  |  Market Research
Growth Opportunities in the Western European IVD Industry, Forecast to 2021
Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...
$4,950.00 -
17 Jan 2017  |  Europe  |  Market Research
Game-changing Strategies of European Pharma Companies
Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study...
$1,500.00 -
15 Jul 2016  |  Europe  |  Market Research
Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe
Sector Convergence is Generating Growth Opportunities Across the Value Chain
Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...
$1,500.00 -
01 Jul 2016  |  Europe  |  Market Research
Western Europe Point-of-Care Testing (POCT) Market
Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...
$4,950.00 -
24 Jun 2016  |  Europe  |  Market Research
Business Analytics in Life Sciences
The Time is Ripe for a Technology Revamp in Clinical Trials
The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in ...
$3,000.00 -
04 May 2016  |  Europe  |  Market Research
European Autoimmune Diagnostics Market, Forecast to 2020
Ageing Population and High Disease Prevalence to Trigger Growth, Localised Disease Segment Offers Revenue Potential
The high prevalence of diseases in Europe is a market opportunities for the market participants, especially considering the ageing population in these regions. This leads to the need for better and early diagnosis. This market includes revenues from instruments and reagents. Market revenues and installed base (units) for the entire Western Europe, ...
$1,500.00